Paragon Banking Group PLC logo

Paragon Banking Group PLC (46P1)

Market Open
12 Jun, 20:00
XSTU XSTU
8. 80
+0.15
+1.7341%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
8.65
Previous Close
Add Transaction
Day Range
8.55 8.8
Year Range
7.95 10.9
Want to track 46P1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

46P1 trading today higher at €8.8, an increase of 1.7341% from yesterday's close, completing a monthly increase of 2.3256% or €0.2. Over the past 12 months, 46P1 stock lost -9.7436%.
46P1 is not paying dividends to its shareholders.
The last earnings report, released on Jun 02, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Paragon Banking Group PLC has completed 1 stock splits, with the recent split occurring on Jan 29, 2008.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on XSTU (EUR).

46P1 Chart

Paragon Banking Group PLC (46P1) FAQ

What is the stock price today?

The current price is €8.80.

On which exchange is it traded?

Paragon Banking Group PLC is listed on XSTU.

What is its stock symbol?

The ticker symbol is 46P1.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Paragon Banking Group PLC ever had a stock split?

Paragon Banking Group PLC had 1 splits and the recent split was on Jan 29, 2008.

Paragon Banking Group PLC Profile

Mortgage Real Estate Investment Trusts (REITs) Industry
Financials Sector
Kai Sun CEO
XSTU Exchange
GB00B2NGPM57 ISIN
AU Country
6 Employees
5 Feb 2026 Last Dividend
29 Jan 2008 Last Split
- IPO Date

Overview

TrivarX Limited, initially known as Medibio Limited, is a pioneering health technology company focused on the advancement of mental health care through innovative detection and screening technologies. Founded in 1987 and headquartered in Mount Lawley, Australia, the company has expanded its operations to both Australia and the United States. With a strong commitment to improving mental well-being, TrivarX Limited serves a dual market comprising both businesses seeking corporate health solutions and healthcare providers looking for effective tools in mental health diagnosis and management. In October 2023, the company underwent a significant rebranding to TrivarX Limited, marking a new chapter in its mission to enhance mental health care globally.

Products and Services

TrivarX Limited offers a range of innovative solutions designed to support mental well-being in various settings:

  • Corporate Health Product: This service is tailored for businesses aiming to safeguard and enhance the mental health of their employees. By integrating TrivarX's cutting-edge technologies, companies can access effective tools for early detection and ongoing screening of mental health conditions, thereby fostering a healthier workplace environment.
  • Healthcare Provider Products: Developed with healthcare professionals in mind, these products facilitate the accurate assessment and management of mental health conditions. TrivarX Limited leverages advanced technology to provide reliable, evidence-based solutions that aid in the diagnostic process, offering a valuable resource for practitioners in the mental health field.

Contact Information

Address: 647 Beaufort Street
Phone: 61 8 6189 1155